🔴 STAAR Surgical is trading 5.5% down today after adjusted EPS missed estimates

STAAR Surgical is trading 5.46% down now at $24.75 after investors reassessed its August 12 earnings outlook.

• Q2 revenue beat estimates, but adjusted EPS came in at $0.16 versus expected $0.22.
• Management offered cautious second-half commentary without formal guidance; China tariffs remain a margin headwind.
• Jefferies cut its price target after the report, while UBS also reduced its target to $19.